ES2068810T3 - Preparacion particulada de liberacion mantenida y procedimiento para la produccion de la misma. - Google Patents
Preparacion particulada de liberacion mantenida y procedimiento para la produccion de la misma.Info
- Publication number
- ES2068810T3 ES2068810T3 ES87114584T ES87114584T ES2068810T3 ES 2068810 T3 ES2068810 T3 ES 2068810T3 ES 87114584 T ES87114584 T ES 87114584T ES 87114584 T ES87114584 T ES 87114584T ES 2068810 T3 ES2068810 T3 ES 2068810T3
- Authority
- ES
- Spain
- Prior art keywords
- preparation
- particulated
- procedure
- production
- same
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE DESCRIBE UNA PREPARACION DE LIBERACION CONTROLADA, EN FORMA DE PARTICULAS, DE UN AGENTE FARMACOLOGICAMENTE ACTIVO, Y UN PROCEDIMIENTO PARA PREPARARLO. LA PREPARACION CONTIENE UN COMPUESTO POLIMERICO CAPAZ DE SER DEGRADADO EN EL CUERPO Y QUE ES BIOCOMPATIBLE, UN AGENTE FARMACOLOGICAMENTE ACTIVO Y UN COMPUESTO NATURAL DE ALTO PESO MOLECULAR DERIVADO DE UN AZUCAR. LA PREPARACION TIENE UN TAMAÑO DE PARTICULA FINA Y UNIFORME Y PUEDE ADMINISTRARSE POR VIA SUBCUTANEA O INTRAMUSCULAR PARA CONSEGUIR UNA ACTIVIDAD FARMACOLOGICA PROLONGADA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61237027A JPH0725689B2 (ja) | 1986-10-07 | 1986-10-07 | 顆粒球コロニ−刺激因子を含有する徐放性製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2068810T3 true ES2068810T3 (es) | 1995-05-01 |
Family
ID=17009307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87114584T Expired - Lifetime ES2068810T3 (es) | 1986-10-07 | 1987-10-06 | Preparacion particulada de liberacion mantenida y procedimiento para la produccion de la misma. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4853226A (es) |
EP (1) | EP0263490B1 (es) |
JP (1) | JPH0725689B2 (es) |
KR (1) | KR930007247B1 (es) |
AT (1) | ATE116540T1 (es) |
AU (1) | AU608250B2 (es) |
CA (1) | CA1315200C (es) |
DE (1) | DE3750943T2 (es) |
ES (1) | ES2068810T3 (es) |
GR (1) | GR3015485T3 (es) |
Families Citing this family (93)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2670680B2 (ja) * | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
US5129877A (en) * | 1988-04-29 | 1992-07-14 | University Of Georgia Research Foundation, Inc. | Receptor-mediated delivery system |
US5271945A (en) * | 1988-07-05 | 1993-12-21 | Takeda Chemical Industries, Ltd. | Sustained release microcapsule for water soluble drug |
JP2827287B2 (ja) * | 1988-07-05 | 1998-11-25 | 武田薬品工業株式会社 | 水溶性薬物含有徐放型マイクロカプセル |
US5041292A (en) * | 1988-08-31 | 1991-08-20 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
JPH02212436A (ja) * | 1989-02-14 | 1990-08-23 | Japan Atom Energy Res Inst | 徐放性基剤 |
PH30995A (en) * | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
HU221294B1 (en) * | 1989-07-07 | 2002-09-28 | Novartis Ag | Process for producing retarde compositions containing the active ingredient in a polymeric carrier |
US5538739A (en) * | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
DE59003337D1 (de) * | 1989-10-16 | 1993-12-09 | Danubia Petrochem Polymere | Pressling mit retardierter Wirkstofffreisetzung. |
AT397345B (de) * | 1990-04-04 | 1994-03-25 | Chemiefaser Lenzing Ag | Pharmazeutisches präparat mit verzögerter wirkstofffreisetzung auf basis von hemicellulosen |
JP3249147B2 (ja) * | 1990-06-01 | 2002-01-21 | キリン−アムジエン・インコーポレーテツド | 生理活性蛋白含有経口製剤 |
EP0459516A1 (en) * | 1990-06-01 | 1991-12-04 | Kirin-Amgen, Inc. | Oral dosage form of biologically active proteins |
US5639738A (en) * | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
CA2061703C (en) * | 1992-02-20 | 2002-07-02 | Rudolf E. Falk | Formulations containing hyaluronic acid |
US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
US5990096A (en) * | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
NZ240214A (en) * | 1990-10-16 | 1993-02-25 | Takeda Chemical Industries Ltd | Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs |
IT1247472B (it) * | 1991-05-31 | 1994-12-17 | Fidia Spa | Processo per la preparazione di microsfere contenenti componenti biologicamente attivi. |
US5990095A (en) * | 1991-07-03 | 1999-11-23 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
US5817644A (en) * | 1991-07-03 | 1998-10-06 | Hyal Pharmaceutical Corporation | Targeting of dosages of medicine and therapeutic agents |
US5977088A (en) * | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6022866A (en) * | 1991-07-03 | 2000-02-08 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
WO1994007505A1 (en) * | 1991-07-03 | 1994-04-14 | Norpharmco Inc. | Use of hyaluronic acid and forms to prevent arterial restenosis |
US5792753A (en) * | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
US6103704A (en) * | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
US6147059A (en) * | 1992-02-20 | 2000-11-14 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
US5767106A (en) * | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
JP2651320B2 (ja) * | 1992-07-16 | 1997-09-10 | 田辺製薬株式会社 | 徐放性マイクロスフェア製剤の製造方法 |
EP0595030A3 (en) * | 1992-10-01 | 1995-06-07 | Tanabe Seiyaku Co | Composition of microspheres with several delayed release nuclei and its preparation process. |
TW333456B (en) * | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
JP3390477B2 (ja) | 1993-01-25 | 2003-03-24 | 生化学工業株式会社 | 薬剤組成物及びその製造法 |
US6090925A (en) | 1993-03-09 | 2000-07-18 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
US5478355A (en) * | 1993-03-18 | 1995-12-26 | United States Surgical Corporation | Method for improving the in vivo strength retention of a bioabsorbable implantable medical device and resulting medical device |
NZ250844A (en) * | 1993-04-07 | 1996-03-26 | Pfizer | Treatment of non-insulin dependant diabetes with peptides; composition |
US6284727B1 (en) * | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
IL110787A0 (en) * | 1993-08-27 | 1994-11-11 | Sandoz Ag | Biodegradable polymer, its preparation and pharmaceutical composition containing it |
EP2283821A1 (en) * | 1993-11-19 | 2011-02-16 | Alkermes, Inc. | Preparation of biodegradable microparticles containing a biologically active agent |
AUPM572294A0 (en) * | 1994-05-18 | 1994-06-09 | Vaccine Technologies Pty. Ltd. | Delivery vehicle for bioactive molecule |
ATE192334T1 (de) | 1995-11-09 | 2000-05-15 | Microbiological Res Authority | Mikroverkapselte dna zur impfung und gentherapie |
US6270795B1 (en) | 1995-11-09 | 2001-08-07 | Microbiological Research Authority | Method of making microencapsulated DNA for vaccination and gene therapy |
KR100236771B1 (ko) * | 1997-04-01 | 2000-02-01 | 성재갑 | 히아루론산을 이용한 약물의 서방성 미세입자 제형 |
US5792477A (en) * | 1996-05-07 | 1998-08-11 | Alkermes Controlled Therapeutics, Inc. Ii | Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent |
US20020182258A1 (en) * | 1997-01-22 | 2002-12-05 | Zycos Inc., A Delaware Corporation | Microparticles for delivery of nucleic acid |
IL136230A0 (en) * | 1997-11-28 | 2001-05-20 | Roche Diagnostics Gmbh | An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes |
GB9810236D0 (en) * | 1998-05-13 | 1998-07-08 | Microbiological Res Authority | Improvements relating to encapsulation of bioactive agents |
FR2778847A1 (fr) * | 1998-05-20 | 1999-11-26 | Jean Pierre Perraud | Implant injectable en sous gingival resorbable, constitue de microspheres a liberation prolongee et chargees en principes actifs et en suspension dans un gel vecteur |
ES2253851T3 (es) | 1998-08-07 | 2006-06-01 | Curis, Inc. | Composicion farmaceutica estable de proteinas hedgehog y uso de la misma. |
IL144597A0 (en) * | 1999-02-03 | 2002-05-23 | Powderject Res Ltd | Hydrogel particle formulations |
US6204308B1 (en) | 1999-03-01 | 2001-03-20 | Novartis Ag | Organic compounds |
DE60036863T2 (de) * | 1999-03-25 | 2008-07-31 | Metabolix, Inc., Cambridge | Medizinische vorrichtungen und verwendungen von polyhydroxyalkanoatpolymeren |
US7582311B1 (en) * | 1999-10-15 | 2009-09-01 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
US7651703B2 (en) | 1999-10-15 | 2010-01-26 | Genentech, Inc. | Injection vehicle for polymer-based formulations |
US8435939B2 (en) | 2000-09-05 | 2013-05-07 | Biokine Therapeutics Ltd. | Polypeptide anti-HIV agent containing the same |
CN1537018A (zh) | 2001-05-23 | 2004-10-13 | 田边制药株式会社 | 一种用于软骨疾病再生治疗的组合物 |
WO2002094321A1 (fr) | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | Compositions favorisant la guérison d'une fracture osseuse |
EP1408876A4 (en) | 2001-06-22 | 2004-09-22 | Durect Corp | ZERO ORDER COAXIAL IMPLANTS WITH EXTENDED RELEASE |
US20050191361A1 (en) * | 2001-08-03 | 2005-09-01 | Powederject Research Ltd. | Hydrogel particle formation |
EP2426139B1 (en) | 2002-08-27 | 2014-10-01 | Biokine Therapeutics Ltd. | CXCR4 antagonist and use thereof |
US20040226620A1 (en) | 2002-09-26 | 2004-11-18 | Daniel Therriault | Microcapillary networks |
BR0314911A (pt) * | 2002-10-22 | 2005-09-27 | Japan Science & Tech Agency | Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal |
US7053125B2 (en) | 2002-11-14 | 2006-05-30 | The Board Of Trustees Of The University Of Illinois | Controlled dispersion of colloidal suspension by comb polymers |
EP1638615B1 (en) * | 2003-05-08 | 2014-10-29 | Tepha, Inc. | Polyhydroxyalkanoate medical textiles and fibers |
US7141617B2 (en) | 2003-06-17 | 2006-11-28 | The Board Of Trustees Of The University Of Illinois | Directed assembly of three-dimensional structures with micron-scale features |
ES2395077T3 (es) * | 2003-07-08 | 2013-02-08 | Tepha, Inc. | Matrices poli-4-hidroxibutirato para una administración prolongada de medicamentos |
AU2004268560B2 (en) * | 2003-08-22 | 2008-08-21 | Tepha, Inc. | Polyhydroxyalkanoate nerve regeneration devices |
US7867511B2 (en) | 2004-01-23 | 2011-01-11 | Travanti Pharma Inc. | Abuse potential reduction in abusable substance dosage form |
FI116625B (fi) | 2004-01-28 | 2006-01-13 | Macrocrystal Oy | Menetelmä proteiinien kiteyttämiseksi hiilihydraattirunkoisilla polymeereillä |
US20050271726A1 (en) * | 2004-06-02 | 2005-12-08 | Albert Crum | Immune enhancing compositions and methods of use thereof |
ES2362217T3 (es) * | 2004-08-03 | 2011-06-29 | Tepha, Inc. | Suturas de polihidroxialcanoato no rizadas. |
WO2006081517A2 (en) * | 2005-01-28 | 2006-08-03 | Tepha, Inc. | Embolization using poly-4-hydroxybutyrate particles |
DE102006013531A1 (de) * | 2006-03-24 | 2007-09-27 | Lts Lohmann Therapie-Systeme Ag | Polylactid-Nanopartikel |
NZ575334A (en) * | 2006-09-13 | 2012-03-30 | Enhance Skin Products Inc | Cosmetic composition for the treatment of skin and methods thereof |
US7943683B2 (en) * | 2006-12-01 | 2011-05-17 | Tepha, Inc. | Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers |
WO2008075369A2 (en) | 2006-12-21 | 2008-06-26 | Biokine Therapeutics Ltd. | T-140 peptide analogs having cxcr4 super-agonist activity for bone marrow recovery |
US7956102B2 (en) | 2007-04-09 | 2011-06-07 | The Board Of Trustees Of The University Of Illinois | Sol-gel inks |
US7922939B2 (en) | 2008-10-03 | 2011-04-12 | The Board Of Trustees Of The University Of Illinois | Metal nanoparticle inks |
US8187500B2 (en) | 2008-10-17 | 2012-05-29 | The Board Of Trustees Of The University Of Illinois | Biphasic inks |
US9155780B2 (en) | 2009-02-11 | 2015-10-13 | Yeda Research And Development Co. Ltd. | Short beta-defensin-derived peptides |
WO2010146578A2 (en) | 2009-06-14 | 2010-12-23 | Biokine Therapeutics Ltd. | Peptide therapy for increasing platelet levels |
EP2841084B1 (en) | 2012-04-24 | 2018-05-30 | Biokine Therapeutics Ltd. | Cxcr4 antagonist peptide for use in the treatment of large cell lung cancer |
CA2958747C (en) | 2014-08-15 | 2022-08-16 | Tepha, Inc. | Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof |
US10626521B2 (en) | 2014-12-11 | 2020-04-21 | Tepha, Inc. | Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof |
WO2016094669A1 (en) | 2014-12-11 | 2016-06-16 | Tepha, Inc. | Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof |
WO2017009842A2 (en) | 2015-07-16 | 2017-01-19 | Biokine Therapeutics Ltd. | Compositions and methods for treating cancer |
BR112018016924A2 (pt) | 2016-02-23 | 2019-01-02 | Biokine Therapeutics Ltd | método de seleção de regime de tratamento para indivíduo que tem leucemia mieloide aguda (lma), método de maximização de resposta ao tratamento de leucemia mieloide aguda (lma), método de tratamento de lma, antagonista de cxcr4 e agente quimioterápico no tratamento de lma |
WO2018138267A1 (en) | 2017-01-27 | 2018-08-02 | Cinfa Biotech S.L. | Method for determining the efficacy of a g-csf containing composition |
US11389844B2 (en) | 2018-03-20 | 2022-07-19 | Verde Environmental Technologies, Inc. | Blister pack disposal system |
CN115970051B (zh) * | 2023-02-09 | 2023-08-29 | 辽宁天贺生物科技研究院有限公司 | 可降解组织工程填充材料及其制备方法和用途 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3045135A1 (de) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
JPS57120518A (en) * | 1981-01-19 | 1982-07-27 | Tanabe Seiyaku Co Ltd | Preparation of microcapsule |
IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
ATE37983T1 (de) * | 1982-04-22 | 1988-11-15 | Ici Plc | Mittel mit verzoegerter freigabe. |
JPS5933214A (ja) * | 1982-08-19 | 1984-02-23 | Mitsui Toatsu Chem Inc | 微小球に製剤された制ガン剤の製造方法 |
CH660488A5 (en) * | 1982-12-17 | 1987-04-30 | Sandoz Ag | (Co)oligomeric hydroxycarboxylic acid derivatives, the preparation thereof, and the use thereof in pharmaceutical compositions |
JPS60112713A (ja) * | 1983-11-21 | 1985-06-19 | Sumitomo Chem Co Ltd | 有用な徐放性注射剤 |
DE3484951D1 (de) * | 1983-10-14 | 1991-09-26 | Sumitomo Pharma | Verlaengerte praeparate mit verzoegerter abgabe. |
EP0140255B1 (en) * | 1983-10-14 | 1991-05-15 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release injections |
JPS60100516A (ja) * | 1983-11-04 | 1985-06-04 | Takeda Chem Ind Ltd | 徐放型マイクロカプセルの製造法 |
GB8416234D0 (en) * | 1984-06-26 | 1984-08-01 | Ici Plc | Biodegradable amphipathic copolymers |
JPS61227526A (ja) * | 1984-07-25 | 1986-10-09 | Chugai Pharmaceut Co Ltd | 新規なコロニー刺激因子 |
JPS6163613A (ja) * | 1984-09-04 | 1986-04-01 | Mitsui Toatsu Chem Inc | 顆粒状に調整された徐放性製剤 |
JPS6165816A (ja) * | 1984-09-10 | 1986-04-04 | Mitsui Toatsu Chem Inc | 顆粒状の徐放性製剤 |
EP0187703B1 (en) * | 1985-01-11 | 1992-08-05 | Teijin Limited | Sustained release preparation |
ATE65798T1 (de) * | 1985-02-08 | 1991-08-15 | Chugai Pharmaceutical Co Ltd | Menschlicher granuloxcyt-koloniestimulierungsfaktor. |
JPS61277612A (ja) * | 1985-05-31 | 1986-12-08 | Kiyoshi Morikawa | 接種用徐放性組成物 |
EP0220520B1 (en) * | 1985-09-30 | 1991-09-18 | Chugai Seiyaku Kabushiki Kaisha | Human granulocyte colony stimulating factor |
JPH0725688B2 (ja) * | 1986-03-31 | 1995-03-22 | 住友製薬株式会社 | Csf徐放性製剤 |
-
1986
- 1986-10-07 JP JP61237027A patent/JPH0725689B2/ja not_active Expired - Lifetime
-
1987
- 1987-10-06 CA CA000547960A patent/CA1315200C/en not_active Expired - Lifetime
- 1987-10-06 KR KR1019870011169A patent/KR930007247B1/ko not_active IP Right Cessation
- 1987-10-06 DE DE3750943T patent/DE3750943T2/de not_active Expired - Lifetime
- 1987-10-06 AU AU79404/87A patent/AU608250B2/en not_active Expired
- 1987-10-06 AT AT87114584T patent/ATE116540T1/de not_active IP Right Cessation
- 1987-10-06 EP EP87114584A patent/EP0263490B1/en not_active Expired - Lifetime
- 1987-10-06 ES ES87114584T patent/ES2068810T3/es not_active Expired - Lifetime
- 1987-10-07 US US07/105,887 patent/US4853226A/en not_active Expired - Fee Related
-
1995
- 1995-03-20 GR GR950400616T patent/GR3015485T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US4853226A (en) | 1989-08-01 |
AU608250B2 (en) | 1991-03-28 |
GR3015485T3 (en) | 1995-06-30 |
EP0263490A3 (en) | 1990-05-16 |
KR880004802A (ko) | 1988-06-27 |
JPS6391325A (ja) | 1988-04-22 |
DE3750943D1 (de) | 1995-02-16 |
CA1315200C (en) | 1993-03-30 |
JPH0725689B2 (ja) | 1995-03-22 |
DE3750943T2 (de) | 1995-05-11 |
EP0263490A2 (en) | 1988-04-13 |
KR930007247B1 (ko) | 1993-08-04 |
ATE116540T1 (de) | 1995-01-15 |
AU7940487A (en) | 1988-04-14 |
EP0263490B1 (en) | 1995-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2068810T3 (es) | Preparacion particulada de liberacion mantenida y procedimiento para la produccion de la misma. | |
US4767628B1 (es) | ||
IL78826A (en) | Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom | |
AU576365B2 (en) | Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas | |
DE3877492D1 (de) | Pharmazeutisches praeparat mit verzoegerter abgabe eines dihydropyridins und eines beta-adrenorezeptor-antagonisten und herstellungsverfahren dessen. | |
CA2123049A1 (en) | Pharmaceutical containing the p40 subunit of interleukin 12 | |
HUT60436A (en) | Process for producing pharmaceutical composition active mainly on thrombo-embolitic conditions of circulatory system and heart | |
GB8825410D0 (en) | Article for controlled release & delivery to animal tissue of pharmacologically active agent | |
ES2029228T3 (es) | Procedimiento para la produccion de un preparado retardado de ibuprofeno. | |
AU2791689A (en) | Medicinal preparation comprising the association of colistin,tobramycin and amphotericin b administered by atomization | |
ZA884622B (en) | Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance | |
ATA379182A (de) | Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung | |
IL81232A0 (en) | Pharmaceutical composition with sustained release of the active component and a process for the preparation thereof | |
HUT47233A (en) | Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients | |
FR2613223B1 (fr) | Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation | |
HUT52958A (en) | Process for production of medical compositions assuring the constant release of the active substance | |
ZA88358B (en) | Oral pharmaceutical preparation with delayed release of active substance | |
JPS6463521A (en) | Trapidyl-containing drug composition, manufacture and related therapeutical use | |
DE3878154D1 (de) | Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid. | |
HUT48880A (en) | Insecticides and acaricides comprising new n-benzoyl-n'-thienyl urea derivative as active ingredient and process for producing the active ingredients | |
HU906990D0 (en) | Process for preparing medical tea mixture having effectivity to breathing system and applicable for medical activity and preventing diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 263490 Country of ref document: ES |